Table 2.
IBD-Related and CDI-Related Characteristics*
| Characteristics | UC (n = 70) | CD (n = 63) | IC (n = 4) |
|---|---|---|---|
| IBD activity before CDI | |||
| Any colon surgery | 1 (1) | 15 (24) | 0 (0) |
| Any small bowel resection | 0 (0) | 6 (10) | 0 (0) |
| ≥1 IBD-related hospitalization within 1 year | 19 (27) | 34 (54) | 1 (25) |
| ≥1 IBD exacerbation within 1 year | 49 (70) | 41 (65) | 1 (25) |
| ≥1 corticosteroid regimen within 1 year | 42 (60) | 35 (56) | 1 (25) |
| IBD medication at time of CDI | |||
| Corticosteroid | 37 (53) | 28 (44) | 3 (75) |
| 5-aminosalicylic acid derivative | 46 (66) | 8 (13) | 1 (25) |
| Immunomodulator | 14 (20) | 20 (32) | 0 (0) |
| Biologic | 10 (14) | 16 (25) | 0 (0) |
| Tacrolimus | 11 (16) | 3 (5) | 2 (50) |
| History of CDI | |||
| No prior CDI | 46 (66) | 48 (76) | 3 (75) |
| ≥1 prior CDI within 1 year | 16 (23) | 7 (11) | 0 (0) |
Abbreviations: CD, Crohn’s disease; IC, indeterminate colitis; UC, ulcerative colitis.
*Data are presented as No. (%).